BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24960648)

  • 1. Therapeutic leukapheresis: 9-year experience in a University Hospital.
    Parra Salinas IM; González Rodriguez VP; García-Erce JA
    Blood Transfus; 2015 Jan; 13(1):46-52. PubMed ID: 24960648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
    Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
    Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
    Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
    Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-chemotherapy white blood cell depletion by therapeutic leukocytapheresis in leukemia patients: A single-institution experience.
    Nguyen TH; Bach KQ; Vu HQ; Nguyen NQ; Duong TD; De Reys S; Wheeler J
    J Clin Apher; 2020 Apr; 35(2):117-124. PubMed ID: 31829470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10
    Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J;
    Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
    Daver N; Kantarjian H; Marcucci G; Pierce S; Brandt M; Dinardo C; Pemmaraju N; Garcia-Manero G; O'Brien S; Ferrajoli A; Verstovsek S; Popat U; Hosing C; Anderlini P; Borthakur G; Kadia T; Cortes J; Ravandi F
    Br J Haematol; 2015 Mar; 168(5):646-53. PubMed ID: 25312977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis.
    Pham HP; Schwartz J
    Transfusion; 2015 Oct; 55(10):2306-11; quiz 2305. PubMed ID: 26267387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.
    Jin Y; Guo S; Cui Q; Chen S; Liu X; Wei Y; Pan Y; Tang L; Huang T; Shen H; Xu G; Zuo X; Liu S; Xiao H; Chen F; Gong F; Zhou F
    Sci Rep; 2018 Jan; 8(1):294. PubMed ID: 29321527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
    J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
    Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
    Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate.
    Porcu P; Danielson CF; Orazi A; Heerema NA; Gabig TG; McCarthy LJ
    Br J Haematol; 1997 Aug; 98(2):433-6. PubMed ID: 9266944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment in adult patients with acute myeloid leukemias and hyperleukocytosis at disease onset].
    Troitskaya VV; Parovichnikova EN; Sokolov AN; Kokhno AV; Kuzmina LA; Badmazhapova DS; Fidarova ZT; Gavrilina OA; Sidorova AA; Galstyan GM; Keselman SA; Gaponova TV; Galuzyak VS; Kravchenko SK; Gribanova EO; Savchenko VG
    Ter Arkh; 2015; 87(7):33-40. PubMed ID: 26390723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
    Aqui N; O'Doherty U
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
    Malkan UY; Ozcebe OI
    Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.